Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy ; volume:7 ; number:1 ; day:12 ; month:4 ; year:2007 ; pages:1-9 ; date:12.2007
BMC cancer ; 7, Heft 1 (12.4.2007), 1-9, 12.2007
- Creator
-
Lee, Kyung-Hun
- Contributor
-
Im, Seock-Ah
Oh, Do-Youn
Lee, Se-Hoon
Chie, Eui Kyu
Han, Wonshik
Kim, Dong-Wan
Kim, Tae-You
Park, In Ae
Noh, Dong-Young
Heo, Dae Seog
Ha, Sung Whan
Bang, Yung-Jue
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-7-63
- URN
-
urn:nbn:de:1111-2016030343421
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Kyung-Hun
- Im, Seock-Ah
- Oh, Do-Youn
- Lee, Se-Hoon
- Chie, Eui Kyu
- Han, Wonshik
- Kim, Dong-Wan
- Kim, Tae-You
- Park, In Ae
- Noh, Dong-Young
- Heo, Dae Seog
- Ha, Sung Whan
- Bang, Yung-Jue
- SpringerLink (Online service)
Other Objects (12)
Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer
Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells
Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
Books received
Catalogues received
Books received
Books received
Books received
Books received
Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer
Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells
Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
Books received
Catalogues received
Books received
Books received
Books received
Books received
Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer
Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells
Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
Books received
Catalogues received
Books received
Books received
Books received